CBSA creates
co-opportunity
for the Colorado
life sciences
community.

Meet the bold, resilient life sciences leaders who drive Innovation Forward.

Read their success stories in our new BioScience Colorado Magazine.

Learn More

Colorado BioScience Institute

Our workforce cultivation activities build knowledge, skills and leadership capabilities.

Learn More

Why Colorado

Our robust economy, collaborative culture, leading academic and research institutions, pro-innovation business climate, and excellent quality of life make Colorado a leading choice to start, scale or relocate a life sciences business.

Learn More

Networking + Events

More
30
Tuesday, Aug 30, 2022
8:30am—12:00pm
Fitzsimons Innovation Community – Bioscience 3
2115 North Scranton Street
Aurora, CO 80045 United States

Next Event

Resources to Fuel Your Ongoing Innovation and Momentum

30
Tuesday, Aug 30, 2022
8:30am—12:00pm
Fitzsimons Innovation Community – Bioscience 3
2115 North Scranton Street
Aurora, CO 80045 United States
J.P. Morgan and Fitzsimons Innovation Community bring you an event focused on resources for early-stage life sciences companies. Hear about how to best engage with the Colorado life sciences community, what resources are available to you through the state, community & grants, policy issues facing the ecosystem, and how to grow your venture with the world's leading healthcare bank. After the program, J.P. Morgan will be available for office hours to answer specific questions and strategize with your start-up. 
Learn More
23
Tuesday, Aug 23, 2022 —
Wednesday, Aug 24, 2022
The American Mountaineering Center
710 10th St
Golden, CO 80401 United States

Next Event

Colorado Capital Conference

23
Tuesday, Aug 23, 2022 —
Wednesday, Aug 24, 2022
The American Mountaineering Center
710 10th St
Golden, CO 80401 United States
Learn More

Stay up to date with one of the country’s most dynamic life sciences ecosystems. Subscribe to the CBSA newsletter today.

Subscribe

Weekly Policy Blog: Deadline Approaches to Reauthorize User Fee Agreements

Learn More

CBSA Remains Active on Critical Federal Legislation

Learn More

Weekly Policy Blog: CBSA’s Continued Advocacy on Important Federal Policy Initiatives

Learn More

Fitzsimons Innovation Community Invests to Meet Market Needs

Learn More

Weekly Policy Update: SBIR/STTR Critical to Life Sciences – Support Our Work on Reauthorization

Learn More

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

Learn More

Terumo Blood and Cell Technologies collaborates with Eliaz Therapeutics in the development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Learn More

SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

Learn More

Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing

Learn More

Weekly Policy Update: Senate Prescription Drug Pricing Legislation

Learn More